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Abstract. Muna L, Astirin OP, Sugiyarto. 2010. Teratogenic test of Pandanus conoideus var. yellow fruit extract to development of rat 
embryo (Rattus norvegicus). Nusantara Bioscience 2: 126-134. This experiment was performed to examine the effect of Pandanus 
conoideus Lam. var. yellow fruit extract on the percentage of the living foetus, the death intrauterus, heavy and long of foetus, foetus 
morphology, and skeleton structur of foetus. The experiment was used by 25 pregnant mice that randomly were divided into 5 groups, 
they contained 5 mice. Each group was given with the different dose. The P1 group (control) was given 1 mL sesame oil, the group P2, 
P3, P4 and P5 were respectively given the yellow fruit extract 0,02 mL, 0,04 mL, 0,08 mL and 0,16 mL. The P. conoideus var. yellow 
fruit extract was given orally on day 5 to 17 of gestation (organogenesis periode). Observation was carried out on day 18 of gestation by 
caesarean section to take the foetus from the uterus. Foetus morphology was observed after taking foetus from uterus, whereas 
observation of skeleton structure was made wholemount preparat with dual colourization, they are Alcian blue and Allizarin Red-S. The 
result was analyzed with one way anova. Results showed that giving yellow fruit extract didn’t influence to the percentage of the living 
foetus, the death intrauterus, heavy and long of foetus. The effect of giving yellow fruit extract to the maternal were abnormality 
skeleton (lordosis) of foetus in the dose 0.16 mL and obstacled to the ossification of foetus. 
Key words: Pandanus conoideus var. yellow fruit, teratogenic, white rat. 
Abstrak.  Muna L, Astirin OP, Sugiyarto. 2010. Uji teratogenik ekstrak Pandanus conoideus varietas buah kuning terhadap 
perkembangan embrio tikus putih (Rattus norvegicus). Nusantara Bioscience 2: 126-134. Penelitian ini betujuan untuk mengkaji 
pengaruh pemberian ekstrak Pandanus conoideus Lam. var. buah kuning terhadap persentase fetus hidup, kematian intrauterus, berat 
dan panjang fetus, keadaan morfologi fetus, serta struktur skeleton fetus tikus putih. Dalam penelitian ini digunakan 25 tikus bunting 
yang dibagi menjadi lima kelompok secara acak, sehingga masing-masing kelompok terdiri dari lima ekor tikus. Setiap kelompok diberi 
dosis yang berbeda. P1 (kontrol) diberi 1 mL minyak wijen, P2, P3, P4 dan P5 diberi ekstrak masing-masing: 0,02 mL, 0,04 mL, 0,08 
mL dan 0,16 mL. Ekstrak tersebut diberikan secara oral pada kebuntingan hari ke 5 sampai hari ke 17 (fase organogenesis). Pengamatan 
dilakukan pada hari ke 18 dengan cara bedah sesar untuk mengambil fetus dari uterus. Morfologi fetus diamati setelah fetus dikeluarkan 
dari uterus, sedangkan untuk pengamatan struktur skeleton dibuat preparat wholemount dengan pewarnaan ganda Alcian blue dan 
Allizarin Red-S. Hasil percobaan dianalisis dengan ANAVA satu jalur. Hasil penelitian menunjukkan bahwa pemberian ekstrak tidak 
berpengaruh terhadap persentase fetus hidup, kematian intrauterus, serta berat dan panjang fetus (P≥0,05). Pemberian ekstrak pada 
induk mengakibatkan kecacatan skeleton (lordosis) fetus pada dosis 0,16 mL dan menghambat osifikasi fetus. 
Kata kunci: Pandanus conoideus var. buah kuning, teratogenik, tikus putih. 
INTRODUCTION 
Cancer is a disease characterized by uncontrolled cell 
growth. Cancer is the second cause of death in the world 
after cardiovascular disease (Ganiswara 2001; Foye 1996). 
Cancer cells in the organs of the body will grow and 
develop in an abnormal, rapid and uncontrolled with the 
cells shape, nature and movement different from its origin 
and cause damage to the form and function of organs 
(Dalimartha 2004). Uncontrolled growths of cancer cells 
push the normal cells around them, because cancer cells 
can metastasize to other body parts (Harkness 1989). 
Treatments to suppress or cure these diseases are 
surgery, radiation, and treatment with chemical compounds 
(Harkness 1989; Alatas 2005). Anti-cancer drug or 
sitostatica are medications that can stop the growth of 
malignant cells or even kill normal cells (Tjay and 
Rahardja 2002). Anti-cancer drugs are teratogenic and can 
not only affect the cancer cells, but can affect normal cells 
(Foye 1996; Ganiswara 2001). The high cost and side 
effects by the presence of cancer therapy (Harkness 1989; 
Harmanto 2001), encourage communities to use anti-cancer 
drugs from plants. 
In Indonesia, there are no less than 2039 species of 
medicinal plants from tropical forests. This situation makes 
Indonesia as one of the world's storehouse of biodiversity 
important for pharmaceutical or medicinal ingredients for 
human health (Zuhud 2009). One of the plants that acts as 
anti-cancer is a red fruit (Pandanus conoideus Lam) 
varieties of P. conoideus var. yellow fruit. These plants MUNA et al. –
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contain various useful chemical compounds (Budiman 
2000). According to Mun'im (2006) mampung red fruit 
extract inhibits tumor growth. Atsirin (2009) and Pratiwi 
(2009) independently proved that the extract of yellow 
varieties of P. conoideus fruit can inhibit the growth of 
T47D breast cancer cells. Hidayati (2010) proved that this 
plant extract could inhibit Hela cell growth. P. conoideus 
var. yellow fruit is a endemic plant of Papua, which has the 
tocopherol and beta-carotene content that act as 
antioxidants. As an antioxidant, both compounds were able 
to ward off free radicals and are thought to help the healing 
process of cancer (Budi and Paimin 2005).  
Gysin et al. (2002) revealed that α-tocopherol could 
inhibit the growth of DU145 prostate cancer cells by 50%, 
LNCaP, prostate cancer cells as much as 48%, and 50% in 
adenocarcinoma colon cancer cell (Caco-2). Consuming 
30-60 mg of beta-carotene daily for 2 months will make the 
body have natural killer cells and more T cells and 
lymphocyte-helpers which are more active. The increase in 
natural killer cells is essential to fight cancer cells and 
control free radicals that disturb health badly (Budi and 
Paimin 2005). The same is stated by Russell (2002) that the 
cancer risks are lower in people who consume vegetables 
and fruits that contain high carotenoids.  
Tocopherol is a form of vitamin E, when consumed 
excessively; it can cause poisoning (Almatsier 2002). And, 
beta-carotene is an vitamin A. The results of experiments 
on animals showed the occurrence of birth defects as a 
result of hipovitaminosis and hipervitaminosis of vitamin A 
during pregnancy (Pergament 1996).  
Anti-cancer drug is used by all cancer patients with 
including pregnant women, while pregnant women are 
particularly vulnerable to drugs, especially during 
organogenesis. Some of drugs that are not allowed to eat by 
pregnant women are anti-cancer drug, because the anti-
cancer drugs are capable of stopping cell division (Nogrady 
1992) and drugs that reach the fetus can cause miscarriage, 
malformation and death of the fetus (Suryawati 1990).  
This study aims to examine the effect of the extract by 
oral administration of external abnormalities in the form of 
percentage of live fetuses, intrauterine death, fetal weight 
and length, and the state of fetal morphology, and internal 
abnormalities of fetal skeleton structure of the white rat (R. 
norvegicus).  
MATERIALS AND METHODS 
Material  
Test animals used were white rat (R. norvegicus), with 
zero day to 2.5 months of pregnancy and an average weight 
of 200 g, pellets Br 2 (PT. Japfa Comfeed Indonesia, 
Sidoarjo) as the daily feed, extracts of P. conoideus var. 
yellow fruit, water to drink and sesame oil as a solvent. 
Sesame oil is packed by PT. Heinz ABC Indonesia, Jakarta).  
Study design  
This research was conducted with experimental 
methods used 25 white rats which were divided into 5 
groups with completely randomized design (CRD). Each 
treatment consisted of 5 replicates. The treatment is as 
follows:  
P1: Control = 1 mL of sesame oil  
P2: The dose of 0.02 mL of extract of P. conoideus var. 
yellow fruit oil and 0.98 mL of sesame oil/200 g BW 
P3: The dose of 0.04 mL of extract of P. conoideus var. 
yellow fruit oil and 0.96 mL of sesame oil/200 g BW 
P4: The dose of 0.08 mL of extract of conoideus var. 
yellow fruit oil and 0.92 mL sesame oil/200 g BW 
P5: The dose of 0.16 mL of extract of P. conoideus var. 
yellow fruit oil and 0.84 mL sesame oil/200 g BW 
Extracts P. conoideus var. yellow fruit and sesame oil 
given orally in the morning and afternoon on gestation day 
of 5 to 17.  
Procedures  
Pre-treatment. Twenty-five white adult female rats (R. 
norvegicus) in estrus cycle were gathered in one cage with 
10 male of white rats. The following day the female rats 
were examined in way of vaginal plug (vaginal plug), if 
there was vaginal plug or after viewed microscopically 
with vaginal smear method and the spermatozoa was 
found, then that day was considered as the first day of 
gestation. Furthermore, female rats were separated from 
white male rats and they were divided into 5 groups, each 
group consisted of 5 female rats.  
Preparation of the animals test. The 2.5 months 
pregnant rats with an average weight of 200 g were kept in 
a cage, each cage contained five mice with the same 
treatment group. The total number of white rats used was 
25. They were divided into five treatment groups. Before 
being used in the study, rats were acclimatized for 4 days, 
and they were given by food and drink. 
Extraction. Preparation of extracts of P. conoideus var. 
yellow fruit refers to Budi and Paimin (2005) as follows: 
the fruit that is mature was selected, the maturity was 
marked with a yellow fruit color and the distance between 
bulges which were rare. The fruit was cleft and the pith was 
discarded, then it was cut and washed. Fruit flesh was 
boiled for 1-2 hours, when it was soft, it was removed and 
cooled. Fruit meat was kneaded until the seeds were 
separated. Water was added up to 5 cm above the surface 
of the material (3:1). This material was squeezed again 
until the seeds seemed white and clean of meat. The result 
was the digest of P. conoideus var. yellow fruit which look 
like coconut milk. The digest was refined to separate juice 
from seeds. The refined digest was cooked in ± 40ºC for 5-
6 hours as it was stirred. If yellow oil was appeared on the 
surface, the flame is turned off and continued the stirring 
for 10 minutes to cool it quickly. Juice was removed and 
was left alone for 1 day until there was the formation of 3 
layers, namely the pulp (bottom layer), water (middle 
layer), and oil (top layer). Oil was taken slowly with a 
spoon and moved into a transparent container, and then it 
was left alone for 3 hours until the oil, water and waste 
were completely separated. With a spoon, the oil was 
moved again carefully into the container. 
Determination of dose usage. The recommended 
dosage of P. conoideus var. yellow fruit is 2-3 times of one 
tablespoon daily (Budi and Paimin 2005), where one  
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tablespoon is equivalent to about 15 mL (Wiryanta 2007). 
That dose is for people with 70 kg of bodyweight. If the 
dose is applied on white rats weighing 200 g, it is obtained: 
X/200g = 15 mL/70 kg Æ X = 0.043 mL = 0.04 mL. The 
determination of dose is also based on the research by 
Pratama (2009) who uses the extract with a concentration 
of 0.03125 mL to T47D breast cancer cells. The results of 
these studies indicate that with this concentration, not all 
T47D breast cancer cells die. While the use of the same oil 
solvent is based on the research by Mun'im (2006) using 1 
mL of sesame oil on the control. The results show that 
there is no abnormality in the fetus due to the use of 1 mL 
of sesame oil. 
Treatment of the animals test. Previously, all rats 
were weighed to determine their initial weight. The extract 
was given orally in each treatment group from day 5
th to 
the 17
th day of gestation, respectively. On the 18th day, the 
surgery was done. Before the surgery process, all rats were 
weighed to determine the final weight. Observations were 
carried out by taking a fetus from the uterus and then it is 
cleaned from the placenta and the mucous membrane 
enveloped it. Fetus external observations began with the 
count and record the number of implantation which 
consists of the number of living fetus, the number of dead 
fetuses, and the number of fetuses that were resorption. 
Furthermore, the body weight, the body length, and the 
fetal morphology were observed including: body shape, 
number of extremities, skull, tail, etc that were considered 
abnormal. The observation was also done on the internal 
skeleton system (bone shape, the amount of bone and the 
process of reinforcement). To study the fetal skeleton 
structure, a wholemount preparations with dual staining method 
of Allizarin red-S and Alcian blue is made (Inouye 1976). 
Wholemount preparations making process was as 
follows: Fetuses were fixed into 95% alcohol for 3 days. 
Viscerasi is the disposal process of skin, fat tissue and 
internal organs of the fetus. This process was done very 
carefully as not to damage the fetus nor change the fetal 
organ position. White rat fetuses were put into acetone for 
1 day to dissolve fat. Fetuses were stained on day 4
th using 
a double staining namely Allizarin red-S and Alcian blue 
for 1-3 days at 37 º C temperature. Fetuses were washed 
with running water for several times until they were clean. 
Fetuses were clarified with 1% of KOH solution in water 
for 2 days until the tissues that wrap the body become 
transparent and the ones that have red or blue color were 
only bone tissues. Fetus transferred into 20% of glycerin 
solution in 1% of KOH for 1-4 days. In a row, fetuses were 
inserted in a solution of glycerol 50% and 80% in KOH 1% 
respectively for 1 hour, and then were stored in 100% of 
glycerin for later observation. Observations on the results 
of ossification were based on of the dye absorption of 
skeleton. True normal bone turns red and inhibited growth 
bone will be blue or no color at all as a dyeing reaction of 
Allizarin Red-S. The photographing of fetal was performed 
at the time of abnormalities observation, both external 
(abnormalities of morphology, hemorrhage, and resorption) 
and internal (ossification abnormalities) using a digital 
camera.  
Collection of data. The quantitative data was obtained 
by observing the number of implantation consists of the 
number of live fetuses, number of dead fetuses, fetal 
weight, and fetal body length. The qualitative data was 
obtained by observing the morphology of the fetus (eyes, 
ears, knuckles, skulls, tails and others that are considered 
abnormal) and its skeleton system (bone shape, number of 
bones, and the process of reinforcement).  
Data analysis  
Quantitative data were analyzed using single lane of 
analysis of variance (ANOVA) with significance level of 
5% to know the real differences among the treatments. If 
the analysis of variance obtained significant results, it 
continued with Duncan multiple range test (DMRT) to 
know the difference. For the observation of external and 
internal abnormalities (the abnormalities of ossification 
results) a descriptive analysis was conducted. 
RESULTS AND DISCUSSION 
Pandanus conoideus var. yellow fruit is one of the 
alternative medicines to cope with cancer (Budi and Paimin 
2005). Anti-cancer drug is used by all cancer patients, 
including pregnant women, while pregnant women are 
particularly vulnerable to drugs, especially during 
organogenesis (Briggs et al. 2008). Anti-cancer drugs are 
teratogenic; not only affects the cancer cells, but can affect 
the normal cells around it (Ganiswara 2001; Foye 1996).  
Fetal tissue grows rapidly, the cells divide rapidly so it 
is very vulnerable to anti-cancer drug. In addition, the 
drugs consumed by the parent will move to the fetus 
through the placenta, namely the same path in which the 
nutrients needed for growth and development of the fetus 
go through. Drugs that reach the fetus can cause miscarriage, 
malformation or even death of the fetus (Suryawati 1990).  
White rat fetal external abnormalities 
In this study, external abnormalities were observed in a 
morphometry way by seeing the occurrence of 
reproduction of white rats parent by counting the number 
of live fetuses, the number of intrauterine death (dead 
fetuses and resorption), measuring weight and length of 
fetal body and observing the abnormalities in the form of 
hemorrhage and deformity in some parts of fetal body 
(Table 4).  
Fetal morphometry 
Fetal weight and length are important parameter to be 
observed in teratogenic research. Wilson (1973) states that 
the decrease in fetal body weight and length is the lightest 
form of an effect of teratogenic compound. Fetal body 
weight and length is a parameter that is sensitive enough to 
determine the effect of foreign compounds on the growth 
of a fetus. There were changes in fetal body weight and 
length ranging from the control group until the group 
treated with the highest dose (Table 4).  
Based on statistical analysis, weight and average length 
of fetuses between treatment groups were not significantly MUNA et al. –
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different (P> 0.05). The result of variance analysis is 
supported by the analysis of correlation between the dose 
with fetal weight and between fetal length with doses. R 
value between the dose with body weight was 0.265 (weak 
correlation). Probability value was > 0.05 (0.200> 0.05), 
then H0 was accepted. It means that the relationship 
between doses with fetal body weight was not significant at 
the level of 95%. While the value of r between dose with 
fetal length is 0.123 (the correlation was very weak). 
Probability value was > 0.05 (0.559> 0.05), it could be 
concluded that the relationship between dose with fetal 
length is not significant at the level of 95%. 
Beta-carotene and tocopherol in a certain amount are 
needed by the body because it is a vitamin that is important 
for the body, but if there's too much, it would be toxic 
(Almatsier 2002). The results of Azman’s study (2001) said 
that, vitamin A and E effect weight gain of normal rats and 
rats with treatment of diovariectomy (removal of two 
ovaries). In this study, weight gain primarily is due to the 
increase of fat mass. Tocopherol and beta-carotene are fat 
soluble vitamins that are lipophilic, allowing it to easily cross 
the placenta.  
Tocopherol and beta-carotene are absorbed in the 
intestines along with the fat or oil consumed. One of the 
reasons why the extract is taken orally is because 
tocopherol and beta-carotene are not water soluble, which 
means it also not soluble in blood plasma. In order for these 
vitamins can be transported into the blood circulation, it 
must bind to proteins (lipoproteins), which is then absorbed 
by the lymphatic system. From the lymphatic system, these 
vitamins along with VLDL (Very Low Density 
Lipoprotein) go into the blood circulation. Some go to the 
needed part and the others go to the liver through the 
ductus toracicus which later merged with triglyceride-rich 
VLDL and HDL (High Density Lipoprotein) which is rich 
in phospholipids, cholesterol and esters. VLDL and HDL 
are synthesized by the liver. Then E vitamin will be back 
into the blood vessels and then converted to LDL (Low 
Density Lipoprotein) by the help of the enzyme of 
lipoprotein lipase in the blood. Furthermore, the vitamins in 
LDL transported to adipose tissue.  
There are three types of entry of drugs through the 
placenta, namely: Type 1, drugs with a balanced 
concentration between mother and fetus; Type II, drugs 
that have a concentration in fetal plasma is higher than the 
concentration in maternal plasma or an excessive transfer is 
happened. This may occur because of the flowing out 
transfer of fetal drug is slower; Type 3, drugs that have a 
concentration in fetal plasma is lower than the 
concentration in maternal plasma or an incomplete transfer 
is happened (Nindya 2001). 
Fetal body weight tends to increase due to the 
tocopherol contained in P. conoideus var. yellow fruit. 
Tocopherol is stored in the liver and fat tissue, so that if 
fetuses are deficient in E vitamin, the tocopherol may be 
used again soon. In addition, if there is damage to fetal 
cells, then the fetus can immediately make the recovery, 
because the fetal cells are still actively dividing, so damage 
to the cell can be easily replaced with another normal cell. 
Normal levels of A vitamin in plasma is 100-120 
units/dL. The requirements of A vitamin in pregnant 
women is > 200 RE (Dewoto 2007). The content of A 
vitamin in P. conoideus var. yellow fruit is 240 ppm (240 
mg/L), so that meet nutrient adequacy rate for pregnant 
women. While the requirement of E vitamin for pregnant 
woman is 10 mg. The content of E vitamin on P. conoideus 
var. yellow fruit is 10,400 ppm (10,400 mg/L). E vitamin 
acts as protective of fatty acids from free radical oxidation 
(Almatsier 2002), so the use of high concentration of E 
vitamin has no effect.  
Average normal fetal body length on day 17
th of 
gestation is 19.31 mm, whereas on day 18
th is 20-23 mm 
(Kauffman 1992). Average length of fetuses in this study is 
25 cm, so it can be said that the length of fetuses in this 
study was normal. Besides influenced by the external 
factors namely the inclusion of A and E vitamin in the 
body of the fetus, growth is also influenced by genetic 
factors (Wilson 1973). The decrease or increase in fetal 
body weight and length are associated with the genes 
contained in each individual and the room for its growth. 
PKH (2009), states that the consumption of fat will affect 
the production of progesterone which is essential for 
implantation and as nutrients that are essential for the 
formation of early embryos. Number of embryos in the 
uterus also affects the availability of space for embryonic 
development and blood supply.  
Fetuses which are derived from one uterine sac with a 
little amount of implantation have relative heavier and 
longer size than the fetus from the uterus with a lot of 
implantations. This relates to nutrition received by the 
fetus. The fewer the number of implantation in the uterus, 
the availability of nutrients for the fetus are met, so that the 
fetal weight and length will increase (Zahrah 2008). This 
can be seen in the control group with the largest number of 
implantation compared with treatment group. The control 
group tends to have average lowest body weight and 
length. The treatment group of 0.08 mL and 0.16 mL of 
extract that has the same number of implantation had 
nearly the same weight. 
Percentage of intrauterine death and fetal life  
Fetal death or resorption is a form of intrauterine death. 
Intrauterine death occurred due to the inability of cells to 
repair (recovery) to replace damaged cells with normal 
cells. This is probably because of the large number of 
damaged cells, so there is no balance between damaged 
cells with normal cells. Fetal cells are able to do recovery 
causing fetal survival. Based on the analysis of variance 
with a level of 95%, there are no significant differences for 
the percentage of live fetuses, fetal death and resorption 
between the control group and treatment group. This is 
evidenced by the value (P> 0.05). Fetal death in this study 
was at a dose of 0.02 mL of extract. Fetus is categorized 
into fetal death, when the fetus is fully developed and there 
are no signs of Autolisis, and it gives no respond to a touch 
(Hutahean 2002). The provision of P. conoideus var. 
yellow fruit on the parent does not affect fetal death, 
because the dosages are very small. In addition, A and E 
vitamin contained in P. conoideus var. yellow fruit are 
necessary for fetal growth. Fetal death in this study is likely  
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caused by the process of cell division and disrupted cell 
differentiation, so the fetus can no longer continue its 
development or can be caused by severe functional 
abnormalities so that the fetus can not survive. In addition, 
the dead fetus in the womb has not finished its 
development, so it has smaller size compared to fetuses 
born alive (Setyawati 2009).  
Fetuses which experience resorption are marked by a 
clump of red or yellow-brown color that does not respond 
when touched (Hutahean 2002). Resorption is a 
manifestation of the death of the conceptus (Lu 1995) that 
may occur due to improper body morphology with various 
disabilities and ended with the death (Rugh 1968).  
 
 
 
Figure 9. The morphology of the fetus inside the mother of the 
control and that fed by stem extracts. The arrows show where 
resorption. (A) The uterus containing a normal fetus, (B) The 
uterus containing the fetus resorption, (C) The form resorption.  
 
In this study, resorption presents in all treatment 
groups. Treatment group with the highest number 
resorption is found in 0.02 mL doses of extract (Table 4). 
In the early stages of proliferation, the embryo will respond 
to die or grow normally, because at this stage, cell 
differentiation does not happen yet, so there is no selective 
effect of a teratogenic agent. This is because the cell is still 
totipotent, whereas if it occurs during cell intensive 
differentiation, mobilization and organogenesis, it will 
cause malformations or birth defects, but if it happens after 
the phase of organogenesis, it will cause abnormal 
function. If the effects of teratogens can not be handled by 
the embryo, it can cause embryonic death followed by 
abortion or resorption on rodensia if it occurs in early 
pregnancy, and fetal death in late pregnancy.  
In addition, genetic plays an important role in the death 
in the phase of pre-implantation (resorption). Embryo death 
in pre-implantation stage often occurs due to inbreeding 
marriage. Before implantation, the embryo is more 
susceptible to the influence of genetic mutations and 
chromosomal abnormalities, followed by early embryonic 
death (PKH 2009). Abnormalities of chromosomes can be 
distinguished on the number of chromosome abnormalities 
and chromosome structure. This can occur because of 
failure of the spread of chromosomes or arrangement of 
chromatin in cells that occur during meiosis and mitosis of 
the egg or sperm cells that produce 2 forms poliploid cells. 
Aneuploid is chromosome abnormalities in animals that 
may occur due to the reduction of the normal chromosome 
number (2n-1), while poliploid is the addition of a normal 
chromosome number (2n+1). The abnormalities caused 
resorption. 
Morphology of the fetus-hemorrhage 
There are 4 forms of embryo developmental disorders, 
namely death, deformity, growth inhibition and impaired 
function (Hutahean 2002). Overall, the fetal organs are 
fully developed in this study (body components are 
complete), although there are fetuses with less size than the 
others. In this research, there are three types of external 
abnormalities, such as: transparent skin, growth inhibition 
and humpbacked body (Table 5).  
Transparent skin or which is often referred to 
hemorrhage is an event of blood discharge from the 
cardiovascular system which is accompanied by 
accumulation in tissues (Price and Wilson 1984 in 
Widiyani and Sagi 2001). Hemorrhage is a form of external 
abnormalities that often occur as an effect of a teratogen. In 
this study, Hemorrhage is found on the head, the neck, the 
back and the stomach.  
Fetuses with transparent skin can be found in all 
treatment groups, including the control group (Figure 11). 
This possibility occurs because the extract is given 
repeatedly in high enough doses, so there is high 
concentration in the blood, resulting in osmotic imbalance. 
In normal circumstances, the embryo develops in the 
amniotic fluid that is isotonic with body fluids. The entry 
of foreign substances in tissue can alter the osmotic 
pressure. Osmotic imbalance can cause pressure and 
viscosity of liquid in different parts of the embryo, between 
blood plasma and extra capillary space or between extra-
embryonic and intra-embryonic fluid. This difference 
causes the blood vessels rupture and hemorrhage occurred 
(Wilson 1973).  
In cases of hemorrhage, there is no difference between 
control (sesame oil provision) with treatment group (the 
provision of a mixture of sesame oil and extract). If the red 
blood cells are at hipotonic solution, ie solution in which 
concentration of dissolved substance outside the cell is 
lower than inside the cell, then the red blood cells are lysis 
(rupture). This is due to the absence of cell wall which may 
hinder the process of red blood cell lysis (Zulti 2008).  
 
Table 5. Percentage of external fetal abnormality of R. norvegicus after the provision of extracts to the parent.  
 
Types of external 
abnormalities 
Dose extract 
0 mL  0.02 mL  0.04 mL  0.08 mL  0.16 mL 
Number of fetuses  58   52   44   46   44  
Hemorrhage/transparent skin  14 (24.14%)   15 (28.85%)   4 (9.09%)   12 (26.09%)   6 (13.64%)  
Barriers to growth  0 (0%)  1 (1.92%)  0 (0%)  0 (0%)  0 (0%) 
Body of humpback  0 (0%)  0 (0%)  3 (6.82%)   0 (0%)  0 (0%) 
Total  14 (24.14%)   16 (30.77%)   7 (15.91%)   12 (26.09%)   6 (13.64%)  MUNA et al. –
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14 15 
Figure 14. The development of fetal skeleton R. norvegicus as a result of the provision of 0.02 mL of P. conoideus var. yellow fruit 
extract on the stem. The arrows indicate the area which experiences delayed ossification. A) Skeleton control group: A1. Perfect 
ossification, A2. Transparent skin, perfect ossification. B. Skeleton of 0.02 mL extract treatment groups: 1. Ossification perfect, B2. 
Delayed ossification of os interparietal, B3. Skeleton of stunted fetuses, delayed ossification in the frontal os, os parietal, os interparietal, 
cervical vertebrae, lumbar vertebrae, sacral vertebrae, tibia and fibula, B4. Skeleton of normal fetuses, delayed ossification of os parietal 
(a), os interparietal (b), and cervical vertebrae (c), B5. Skeleton of delayed ossification in the cervical vertebrae. 
  
Figure 15. The development of fetal skeleton R. norvegicus as a result of the provision of 0.04 mL of the extract on the parent. A. 
Skeleton of the normal control group. B. Skeleton of groups of 0.04 mL extract: B1. Normal Skeleton, B2. Skeleton of delayed 
ossification in os interparietal 
 
16 17 
Figure 16. The development of fetal skeleton R. norvegicus from the treatment of 0.08 mL of the extract on the parent. A. Control. B. 
Skeleton 0.08 mL extract treatment groups: B1. Normal fetus, ossification perfect, B2. Fetus transparent skin, perfect ossification, B3. 
Normal fetus, but delayed ossification of interparietal os (a) and cervical vertebrae (b), B4. Skeleton lordosis.  
 
Figure 17. The development of fetal skeleton R. norvegicus from the provision of 0.16 mL of the extract on the parent. A. Skeleton 
control group. B. 0.16 mL extract skeleton groups: B1. Ossification perfect, B2. Skeleton delayed ossification in the lumbar vertebrae, 
B3. The delay in ossification of the cervical vertebrae (a), clavicula (b) and lumbar vertebrae (c).  
 
 
Fetal morphology-growth retardation  
In this study, fetal which experienced growth inhibition 
is only in the treatment group of 0.02 mL of extract (Table 
6). According to Ritter (1977), compounds with low doses 
of teratogens are capable of causing the death of some cells 
and can also cause cell turnover, because the fetal cells 
have high regeneration ability. If one or a group of cells are 
damaged by the interference of toxic agents, the normal 
cells around it will divide and replace the damaged cells. 
The replacement of fetal damaged cells will be maintained 
during the period of organogenesis in order to form a 
normal morphology. If that fails or does not reach the 
target in the phase of organogenesis, it will cause fetal 
malformations, forming morphologically normal, but small.  
Growth inhibition in the fetus may be caused by 
disruption of cell division, namely the nucleic acid and 
protein synthesis are disrupted and then the damaged cells 
can not be repaired. Fetal growth occurs because of cell 
proliferation by mitosis and proliferation rapidity is a 
function of growth velocity (Herbold 1985). In this study, 
growth inhibition on fetuses is caused by cell death due to 
the provision of extract as an anti-cancer which is given at 
the time these cells begin to actively divide, resulting in 
inhibition of cell division. If a foreign substance is given 
continuously, in the process of time, these cells will die. If 
more and more cells die, it will be difficult for fetus to 
develop. 
Fetal morphology-humpback body 
In this study, Humpback body was only found in group 
of 0.04 mL of extract treatment (Figure 13). Normal 
embryogenesis ended with the formation of new 
individuals that shape and structure is the same as its 
parent, but abnormal embryogenesis will end with the 
formation of individuals who vary (Wilson 1973). 
Abnormal shape in the form of humpback body in this 
study is likely caused by a deformity of the vertebrae 
(spine) which is caused by the death of bone cells making 
up some vertebrae, resulting in bone growth rate of one to 
another is not the same, so the bone bends. Fitrianna (2009) 
states that the vertebrae are formed on day 12
th . In this 
study, the extract is given to the parent from day 5
th to day 
17
th. Presumably this cell death is caused by the extract 
given to the parent. Given that the immune response 
against the teratogens substance of each individual is 
different (Wilson 1973), the fetus with a low immune 
system is unable to repair cells, especially spine constituent 
cells which are damaged or die by the presence of 
substances such teratogens.  
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Internal fetal abnormality of white rats 
The observation of internal abnormalities, namely the 
observation on the development of fetal skeleton of R. 
norvegicus wistar strain is by making the wholemount 
preparation. The preparations were made using double 
staining, ie Allizarin Alcian Blue and Red-S. Alcian Blue 
and Red Allizarin-S is a special chemical substance for 
staining bone tissue (Inouye 1976). Alcian Blue will 
perform affinity with the matrix in cartilage tissue, so the 
cartilage will be stained in blue. While Allizarin Red-S will 
perform affinity with the matrix in bone tissue, so the bones 
will be stained in red. The internal abnormalities observed 
included bone structure and results of its ossifications. 
Skeleton comes from the mesoderm. In the mesoderm, 
differentiation occurs including mesoderm of head, body 
and tail which in this level of development is called 
embryonic Mesenchyme. Mesenchyme develops into 
mesoderm structures of the body, including connective 
tissue namely cartilage (cartilage) and bone (Sagi 1997). 
Calcification process occurs in two ways, namely intra-
membrane and endochondric ossification. Intra-membrane 
ossification is the process of bone formation of 
mesenchymal tissue into bone tissue, such as the formation 
of lamellar bone. While ossification endokondral the bone 
formation process that occurs in which mesenchymal cells 
first differentiate into cartilage (cartilage tissue), then 
transformed into bone tissue, such as the formation of long 
bones, vertebrae and pelvis.  
According Loegito et al. (1995) in Ekawati (2002), 
there are three benchmarks to determine the growth and 
development of the skeleton, namely: number of 
components of skeleton and their ossification level, the 
perfect or not the ossification process, 
and the presence or absence of 
abnormalities in the formation of 
skeleton. Based on the observation, the 
results show the presence of delays in 
the process of ossification in all 
treatment doses ranging from lowest to 
highest dose (Table 6).  
The development consists of 
increasing bone size, maturity and age. 
Changes from the development of 
membranous and cartilaginous hard 
bone are called bone maturation. There 
are five periods of bone formation, 
namely: (i) the embryonic period: 
mandible, maxilla, humerus, radius, 
ulna, femur, and fibia, (ii) fetal period: 
scapula, illium, fibula, (iii) cartilage: 
epiphisis on the limb, carpal, tarsal, and 
sesamoids; (iv) adolescent bones: 
scapula, ribs, hip/waist, (v) adult bone 
(Jessop 1988). Abnormalities of 
skeletal malformations found in this 
research is a form of lordosis skeleton 
which is found in 0.16 mL of extract 
treatment group and delayed 
ossification process found in all 
treatment groups. However, the 
treatment group with deformity 
skeleton is mostly found in 0.02 mL of extract treatment 
group (Table 6).  
 
Table 6. Percentage of deformity of fetal R. norvegicus skeleton 
as the result of the provision of the extract to the parent.  
 
Dose of extract of 
P. conoideus var. 
yellow fruit 
Amount 
of parent
Amount 
of fetus 
Amount of 
observed 
fetus 
fetal 
defects 
percentage 
P1 0  5 58  20  0% 
P2 0.02  mL  5 52  12  33.33% 
P3 0.04  mL  5 44  18  5.56% 
P4 0.08  mL  5 46  21  9.52% 
P5  0.16 mL   5  44  9  22.22%  
 
In this study, the bones experiencing delays in 
ossification were found in the Cranium, cervical vertebrae, 
clavicula, lumbar vertebrae, sacral vertebrae, and tibia and 
fibula. The delay in ossification is blue in the fetal skeleton 
and indicates that these bones are still cartilage (cartilage). 
The results shows that 0.02 mL of the extract treated 
group experienced delayed ossification compared to other 
groups. This is most likely influenced by a lack of nutrients 
to the mothers of white rat, so that the metabolic processes 
are inhibited. It is indicated by the presence of very light 
fetal weight compared to fetal weight of other groups, 
namely 0.7 g. The most important nutrient for growth and 
development of bone is calcium (Dewoto 2007). According 
Setiyohadi (2009), calcium holds two important 
physiological roles in the body. In bone, calcium salts play 
a role in the calcification process, so the bones become 
harder. Hardening of the bone serves to sustain weight loss. 
While in the extracellular fluid and cytosol, calcium plays a 
11 
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Figure 10. Morphologically normal fetuses of R. norvegicus. Note: 1. Pinnae, 2. Eye, 
3. Vibrisae, 4. Mouth, 5. Anterior limb, 6. Posterior extremity, 7. Tail 
Figure 11. Comparison of fetal normal skin and fetal transparent skin after 
administration of extract on the parent. Arrows indicate hemorrhage. (A) Fetal normal 
skin, (B1) Fetus transparent skin doses of 0 mL; (B2) Fetus transparent skin dose of 
0.02 mL; (B3) Fetus transparent skin dose of 0.04 mL; (B4) Fetus transparent skin dose 
of 0, 08 mL, (B5) Fetus transparent skin dose of 0.16 mL of extract. 
Figure 12. Comparison of normal fetuses (A) with an experienced fetal growth 
inhibition (B) effect of extract to the parent.  
Figure 13. Comparison of normal fetuses (A) and fetal body humpbacked after 
administration extract to the parent. MUNA et al. –
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role in various biochemical processes of the body in the 
form of calcium ions.  
Norazlina et al. (1999) states that the consumption of 
1% of calcium in rats with low E vitamin can increase bone 
mineral density. The body normally contains 1100 g of 
calcium for body weight of 70 kg. If the dose is converted 
in rats weighing 200 g, then there are 3.14 g of calcium in 
the body of rats. Yuliati et al. (2007) revealed that the 
addition of 27 mg/200 g BW/day can increase the thickness 
of the trabecular bone. Histologically, the bone is divided 
into 2, namely cortical bone and trabecular bone. Cortical 
bone has a mechanical and protective role, whereas 
trabecular bone is metabolical. Bone thickness indicates the 
strength of the bone, because in thick bone, there is an 
abundant amount of minerals.  
Calcium in P. conoideus var. yellow fruit was 15.3 
mg/100 g of material. The dose is very small compared to 
the intake of calcium that is used in research by Yuliati et 
al. (2007). Calcification is the deposition of calcium salts 
and phosphorus in bone matrix. Vitamin D is also needed 
in this process. Vitamin D is a prohormone, so that if the 
body does not get enough sunlight, D vitamin needs to be 
met through food. The conversion of D vitamin into active 
vitamin D3 (calcitriol) occurred in the kidney. In the 
intestine, calcitriol can increase the absorption of calcium 
and phosphorus. The calcitriol synthesis is regulated by 
calcium and phosphorus levels in the blood. When blood 
calcium levels are low, parathyroid hormone will stimulate 
the kidney to produce calcitriol. Role of vitamin D3 in the 
process of bone calcification is by making the calcium and 
the phosphorus available in the blood to be precipitate in 
the bone matrix. Because the amount of calcium used is not 
sufficient with the levels of calcium in the blood, the 
calcification process is inhibited. As a result, the bones still 
have the quality of cartilage. 
There are two primary metabolisms in bone formation 
that are vulnerable to nutritional deficiencies, namely: the 
synthesis protein process to form the organic matrix of 
bone tissue consisting of collagen and non collagen protein. 
The next process is the bone calcification, in this stage; 
minerals such as calcium and phosphorus are precipitated 
in the bone matrix. If there are obstacles in the formation of 
organic matrix, then there will be obstacles in the process 
of calcification of bone resulting in decreased levels of bone 
minerals, including calcium and phosphorus. The occurrence 
of bone calcification resistance will lead to obstacles in the 
formation of osteoclast cells (Setiyohadi 2009). 
Bone regeneration was influenced by two cells, namely 
osteoclasts and osteoblasts. Osteoclasts play role in bone 
reconstruction using acids and enzymes (bone resorption); 
while Osteoclasts play a role in the formation of new bone 
to replace the old bone which is dismantled by Osteoclasts 
(Rebecca and Brown 2007). Osteoclasts are motile cells. 
These cells will do resorption on bone to form lacuna, then 
they will move to another part of the bone. At the time of 
osteoclast cells move, resorption of bone does not occur. 
But when the osteoclast cell stops moving, then the process 
of resorption happens. The increase of bone resorption 
causes a reduction in the amount of bone. 
Santoso (2004), in his study, states that a teratogen 
agents can affect the thickness of cells from the femur of 
mice. The layers on the femur of mice become thinner and 
thinner, and some even die. Teratogen agents are 
accumulated in several organs, especially the organ that is 
undergoing calcification which would result in 
abnormalities in fetal development. This is caused partly 
because the fetus does not have enzymes that can 
metabolize these toxic agents perfectly.  
The presence of fetal skeleton with perfect ossification 
is due to internal factors, namely the hormone that 
maintains bone mass. Rebecca and Brown (2007) states 
that the hormone is one of the factors that influence the 
bone to be strong or not. Hormones are natural substances 
produced by specialized cells in the body. Hormones 
circulate in the bloodstream and can affect cell activity at 
various places in the body. In addition, the hormone can 
also help limiting the amount of bone resorption, because it 
regulates calcium levels in the blood. This is clarified by 
the study of Masyita (2006), that lack of estrogen can cause 
osteoporosis in mice. Osteoporosis occurs due to loss of 
bone mass and increased bone absorption. Estrogen is 
assessed to affect the process of bone destruction by 
inhibiting cytokine production. Estrogen plays an important 
role in the process of homeostasis, namely supporting the 
secretion of calcitonin, as an inhibitor resorption bone and 
can increase levels of D3 vitamin which serves to increase 
the degree of calcium absorption in the intestine. Low 
cytokines may decrease osteoclast activity that plays a role 
in the overhaul of the bone. Cytokines are proteins that 
play a role in the process of bone resorption. There are two 
kinds of cytokines, namely IL-1 and IL-6. IL-1 plays a role 
in stimulating bone resorption, replication of bone cells and 
increase synthesis of IL-6. IL-6 also plays a role in 
undergoing resorption bone by cells to activate osteoclasts. 
Synthesis of IL-6 would be inhibited by estrogen, so the 
intake of estrogen can reduce bone resorption (Norazlina et 
al. 2007). There is a relationship between estrogen with E 
vitamin, namely E vitamin which is a fat soluble vitamin 
may be converted into cholesterol, while cholesterol is the 
precursor of estrogen that its construction is through a 
series of enzymatic reactions. 
Shuid et al. (2010) stated that E vitamin has potential as 
an anabolic agent in bone and can improve bone strength. 
In addition, E vitamin can improve bone structure. 
Anabolic agents are agents that can improve bone strength 
by increasing bone mass. In addition, E vitamin also acts as 
anti-osteoporotic agents (Nazrun et al., 2010). Tocopherol 
contained in P. conoideus var. yellow fruit is E vitamin, 
which plays a role in bone formation. Tocopherol along 
with calcium and vitamin D plays a role in bone 
metabolism process. Calcium plays a role in increasing 
bone mineral density, thus reducing resorption activity on 
bone. E vitamin can increase the density of calcium and D3 
vitamin is required for calcium absorption in intestine and 
for calcium storage in bones (Norazlina et al. 1999).  
Xu et al. (1995) stated that E vitamin can stimulate the 
growth of trabecular bone. Lack of E vitamin can reduce 
the transport of calcium in intestine. E vitamin intake of 
10-30 mg/day is sufficient to maintain normal levels in the 
blood (Dewoto 2007). Norazlina et al. (1999), states that  
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the use of E vitamin by 60 mg/kg BW/day can increase the 
calcium content in rat femur. The content of tocopherol in 
P. conoideus var. yellow fruit is 10,400 ppm (10,400 mg). 
Excess tocopherol will not be discarded, because 
tocopherol is stored in the liver and adipose tissue in the 
form of glycerol and it can be reused by the body any time. 
CONCLUSION 
Morphometry of white rats fetus changes from control 
to highest dose treatment group. There are fetuses that 
have: mortality and growth inhibition at doses of 0.02 mL 
extract; resorption in all treatment groups, ie at a dose of 
0.02 mL, 0.04 mL, 0.08 mL, and 0.16 mL extract; or 
transparent skin presents in the control and in all treatment 
groups. The extract can cause fetal abnormalities in the 
skeleton structure of the white rat. Abnormalities in the 
form of lordosis skeleton is found at a dose of 0.16 mL of 
the extract and the occurrence of ossification barriers can 
be found in all treatment groups. 
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